[AL17]末梢性μオピオイド受容体拮抗薬ナルデメジンの創薬研究
○Toshiyuki Kanemasa1, Masanao Inagaki2, Tsutomu Suzuki3, Takaaki Yokota4, Minoru Hasegawa5(1. 塩野義製薬 経営戦略部経営企画部、2. 塩野義製薬 創薬化学研究所中分子創薬部門 主幹研究員、3. 星薬大薬、4. 塩野義製薬 医薬開発本部プロジェクトマネジメント部、5. 塩野義製薬 医薬研究本部 創薬疾患研究所長)
Password required to view
A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.
